Results 91 to 100 of about 5,322,139 (136)

Targeting FoxO1/3a, NF-κB, and mTOR signaling attenuates muscle atrophy in sepsis. [PDF]

Sci Rep
Fu D, Zhou M, Zhang Y, Cheng P, Shu Y, Xiao Q, Zhang M.   +6 more
europepmc   +1 more source

Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines. [PDF]

Int J Mol Sci
Sattarifard H, Oyeyode M, Prajapati D, Duaqui A, Kaur G, Muker I, Luo W, Lakowski TM, Davie JR.   +8 more
europepmc   +1 more source

Anticancer proteasome inhibitors are detrimental to the growth of Toxoplasma gondii in vitro. [PDF]

BMC Res Notes
Zhang M, Guiton PS.
europepmc   +1 more source

Dynamic Alterations of Site-Specific N-Glycoform and Plasma Proteasome Signatures Stratify Chemotherapy Benefit in Pancreatic Ductal Adenocarcinoma. [PDF]

Mol Cell Proteomics
Gui S, Zhang Y, Xia T, Qian J, Fang Z, Ouyang W, Wang J, Chen J, Ren X, Lyu J, Cui W, Fang H.   +11 more
europepmc   +1 more source

Small bites for big problems: stepwise aggregate degradation by autophagy. [PDF]

Biochem Soc Trans
Hipp MS, Mauthe M.
europepmc   +1 more source

Molecular mechanisms underlying liposarcoma subtype transition and proteasome-associated targeted interventions. [PDF]

J Transl Med
Liu J, Huo M, Wu S, Wang Z, Peng S, Fu Y.   +5 more
europepmc   +1 more source

Fred Goldberg machines in the pathogenesis of Mycobacterium tuberculosis. [PDF]

J Biol Chem
Darwin KH.
europepmc   +1 more source

Integrative Pan-Cancer Mapping of Proteasome Dependency Prioritizes PSMB5 and PSMB6 as Context-Dependent Vulnerability Biomarkers Linked to Immune Context. [PDF]

Molecules
Kim JH, Park H, Kim HJ, Han ME, Lee D, Yoon S, Oh SO.   +6 more
europepmc   +1 more source

Two Mechanisms One Molecule: Developing a 'Truly' Bifunctional Degrader Targeting Rpn13 and CRBN. [PDF]

J Am Chem Soc
Loy CA, Vinogradsky SE, Trader DJ.
europepmc   +1 more source

Honokiol Suppresses Glioma Cell Proliferation by Disrupting SUMO1-YAP1 Conjugation and Promoting YAP1 Proteasomal Degradation. [PDF]

Biomolecules
Sheng Z, Fang Q, Cui S, Wang J, Xiao H, Wu C, Xiang D.   +6 more
europepmc   +1 more source